Cytokine Storm Signature in Patients with Moderate and Severe COVID-19.
COVID-19
chemokines
cytokines
growth factors
multiplex
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
10 Aug 2022
10 Aug 2022
Historique:
received:
29
06
2022
revised:
03
08
2022
accepted:
04
08
2022
entrez:
26
8
2022
pubmed:
27
8
2022
medline:
30
8
2022
Statut:
epublish
Résumé
Hypercytokinemia, found in SARS-CoV-2 infection, contributes to multiple organ dysfunctions with acute respiratory distress syndrome, shock etc. The aim of this study was to describe cytokine storm signatures in patients with acute COVID-19 and to investigate their influence on severity of the infection. Plasma levels of 47 cytokines were investigated in 73 patients with moderate and severe COVID-19 (41 and 32, respectively) and 11 healthy donors (HD). The most elevated levels comparing patients and the HD were observed for seven pro-inflammatory cytokines (IL-6, IL-8, IL-15, IL-18, IL-27, IFNγ, TNFα), three chemokines (GROα, IP-10, MIG), two anti-inflammatory cytokines (IL-1RA, IL-10), and two growth factors (G-CSF, M-CSF). The patients with severe disease had significantly higher levels of FGF-2/FGF-basic, IL-1β, and IL-7 compared to the HD. The two groups of patients differed from each other only based on the levels of EGF, eotaxin, and IL-12 p40. Pneumonia lung injury, characterized by computer tomography, positively correlated with levels of EGF, IP-10, MCP-3 levels and negatively with IL-12 p40. Pro-inflammatory factors including IL-6, TNFα, and IP-10 negatively correlated with the frequency of the circulating T-helper17-like cells (Th17-like) and follicular Th cells that are crucial to develop SARS-CoV-2-specific plasma cells and memory B cells. Obtained data on the cytokine levels illustrate their influence on progression and severity of COVID-19.
Identifiants
pubmed: 36012146
pii: ijms23168879
doi: 10.3390/ijms23168879
pmc: PMC9408700
pii:
doi:
Substances chimiques
Chemokine CXCL10
0
Cytokines
0
Interleukin-6
0
Tumor Necrosis Factor-alpha
0
Interleukin-12
187348-17-0
Epidermal Growth Factor
62229-50-9
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Ministry of Science and Higher Education of the Russian Federation
ID : 075-15-2022-301
Références
Front Genet. 2021 Jun 07;12:680646
pubmed: 34163532
Sci Rep. 2016 May 05;6:25359
pubmed: 27146253
Clin Immunol. 2021 Feb;223:108652
pubmed: 33333256
J Med Virol. 2006 Apr;78(4):417-24
pubmed: 16482545
Viruses. 2022 May 18;14(5):
pubmed: 35632823
Nat Med. 2020 Oct;26(10):1623-1635
pubmed: 32807934
Front Immunol. 2020 Nov 26;11:596553
pubmed: 33324414
Sci Immunol. 2020 Jul 15;5(49):
pubmed: 32669287
Lancet. 2020 Mar 28;395(10229):1033-1034
pubmed: 32192578
J Allergy Clin Immunol. 2020 Jul;146(1):89-100
pubmed: 32407836
Cell Death Dis. 2020 Nov 6;11(11):957
pubmed: 33159040
Nat Med. 2020 Sep;26(9):1428-1434
pubmed: 32661393
J Clin Invest. 2020 May 1;130(5):2620-2629
pubmed: 32217835
Am J Respir Crit Care Med. 2005 Apr 15;171(8):850-7
pubmed: 15657466
Immunity. 2011 Jan 28;34(1):108-21
pubmed: 21215658
Front Immunol. 2021 May 14;12:664209
pubmed: 34054832
Clin Chim Acta. 2020 Sep;508:122-129
pubmed: 32417210
Trends Immunol. 2007 Jan;28(1):33-8
pubmed: 17126601
Sci Rep. 2016 Feb 10;6:20686
pubmed: 26861911
Sci Rep. 2016 May 27;6:26494
pubmed: 27231124
Front Immunol. 2021 May 17;12:659419
pubmed: 34079547
Front Cardiovasc Med. 2021 Dec 17;8:785738
pubmed: 34977191
Cytometry A. 2013 Jun;83(6):530-2
pubmed: 23504907
Sci Transl Med. 2013 Mar 13;5(176):176ra32
pubmed: 23486778
N Engl J Med. 2020 Jul 9;383(2):120-128
pubmed: 32437596
Cytokine. 2018 Apr;104:8-13
pubmed: 29414327
Nat Commun. 2020 Jul 6;11(1):3434
pubmed: 32632085
Sci Immunol. 2020 Sep 17;5(51):
pubmed: 32943497
Oncoimmunology. 2020 Aug 25;9(1):1807836
pubmed: 32939324
Pathogens. 2021 Oct 30;10(11):
pubmed: 34832564
Viruses. 2021 Apr 27;13(5):
pubmed: 33925492
J Leukoc Biol. 2021 Jan;109(1):55-66
pubmed: 32930456
Sci Immunol. 2021 Feb 23;6(56):
pubmed: 33622974
JCI Insight. 2020 May 21;5(10):
pubmed: 32324595
JCI Insight. 2018 Feb 8;3(3):
pubmed: 29415897
JCI Insight. 2021 Jan 11;6(1):
pubmed: 33232303
Vaccines (Basel). 2021 Mar 03;9(3):
pubmed: 33802310
Cytokine. 2012 Sep;59(3):467-78
pubmed: 22704694
Science. 2020 Sep 4;369(6508):
pubmed: 32669297
BMC Infect Dis. 2021 Aug 3;21(1):738
pubmed: 34344353
Mol Med. 2020 Oct 29;26(1):97
pubmed: 33121429
Front Immunol. 2021 Jun 28;12:680188
pubmed: 34262564
World Allergy Organ J. 2021 Mar;14(3):100521
pubmed: 33589865
Nat Med. 2020 Jul;26(7):1070-1076
pubmed: 32514174
Scand J Immunol. 2021 Mar;93(3):e12989
pubmed: 33113222
J Allergy Clin Immunol. 2021 Jul;148(1):40-52
pubmed: 33485651
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Nat Rev Immunol. 2012 Feb 17;12(3):191-200
pubmed: 22343568
Front Immunol. 2021 Dec 06;12:763292
pubmed: 34938289
Am J Kidney Dis. 2022 Feb;79(2):257-267.e1
pubmed: 34710516
Eur J Immunol. 2019 Oct;49(10):1457-1973
pubmed: 31633216
Cell. 2020 Sep 17;182(6):1401-1418.e18
pubmed: 32810439
Biomed Pharmacother. 2022 Jan;145:112419
pubmed: 34781146
Immunity. 2019 May 21;50(5):1132-1148
pubmed: 31117010
Cytokine Growth Factor Rev. 2021 Apr;58:82-91
pubmed: 33573850
Immunity. 2020 Oct 13;53(4):864-877.e5
pubmed: 32791036
Cell. 2022 Mar 3;185(5):916-938.e58
pubmed: 35216673
J Pers Med. 2021 Mar 12;11(3):
pubmed: 33809027
Open Forum Infect Dis. 2020 Nov 26;8(2):ofaa574
pubmed: 33553467
Cell Host Microbe. 2020 Jun 10;27(6):992-1000.e3
pubmed: 32320677
Pathogens. 2022 Feb 01;11(2):
pubmed: 35215138
Eur J Clin Invest. 2021 Jan;51(1):e13429
pubmed: 33058143
Cytokine Growth Factor Rev. 2020 Aug;54:62-75
pubmed: 32513566
J Infect Dis. 2020 Aug 4;222(5):746-754
pubmed: 32563194
Semin Immunol. 2021 Jun;55:101545
pubmed: 34865933
Viruses. 2021 Sep 30;13(10):
pubmed: 34696395
Virol J. 2021 Jun 4;18(1):117
pubmed: 34088317
J Heart Lung Transplant. 2017 Mar;36(3):305-314
pubmed: 27793518